Professor of Ophthalmology, Pathology & Cell Biology at Vagelos College of Physicians and Surgeons, Columbia University, USA
United States
Prof. Tsang is a prominent ophthalmologist and genetic medicine researcher at Columbia University. He has made significant contributions to the field, including generating the world's first gene-targeted model of RP and developing novel therapies. His work has led to preclinical testing of viral-gene therapy for RP. He is ranked among the top RP experts in the world and has received numerous grants and awards for his work.
Prof. Tsang is a prominent figure in the field of ophthalmology and genetic medicine. Currently, he holds the position of Member at the Columbia Stem Cell Initiative and is a Professor of Ophthalmology, Pathology, and Cell Biology at the Vagelos College of Physicians and Surgeons, Columbia University in New York, USA.
His educational background includes a residency in Ophthalmology at Jules Stein Eye Institute, UCLA, a medical degree (M.D.) and a Ph.D. in Genetic Medicine from Columbia University, and a Master of Philosophy (M. Phil.) in Embryonic Stem Cells from Columbia University as well. He also obtained an A.B. in Collagen Genetics from The Johns Hopkins University.
Dr. Tsang's research focuses on retinitis pigmentosa (RP), particularly on cGMP-phosphodiesterase (PDE6) related autosomal recessive RP. He has made significant contributions to the field, including generating the world's first gene-targeted model of retinitis pigmentosa and conducting studies on PDE6 regulation of G-protein-coupled receptor signaling. His work has led to novel discoveries and preclinical testing of therapies, with viral-gene therapy being considered for clinical trials. Dr. Tsang has successfully treated preclinical models of various retinopathies and has expertise in genome engineering strategies, patient-specific knock-in models, and patient care with a precision medicine approach.
His contributions have been widely recognized, and he is ranked among the top RP experts in the world. He has received numerous grants and research support, including the prestigious R01EY024698 and R01EY018213 from the National Institutes of Health (NIH). He has also held various positions and scientific appointments throughout his career, including serving on grant review committees, editorial boards, and advisory panels. Prof. Tsang's expertise and leadership have been sought after by organizations such as the FDA and the Medical Research Council in the UK.
In addition to his academic and research achievements, Prof. Tsang has received several honors and awards for his contributions to the field of ophthalmology. He is an esteemed member of professional societies and has published extensively in scientific journals. Prof. Tsang's dedication to advancing the understanding and treatment of retinal diseases has made a significant impact in the field and has earned him recognition and respect from his peers.
Vagelos College of Physicians and Surgeons, Columbia University, USA
New York-Presbyterian Hospital
Columbia University
Basic Science Course in Ophthalmology
Columbia University
Columbia University
Laboratory of Debora B. Farber, University of California, Los Angeles
Jules Stein Eye Institute (B.J. Mondino, Chairman), UCLA
The Johns Hopkins University
2005
Jules Stein Eye Inst., UCLA, Los Angeles, CA
2003
Laboratories of Peter Gouras and Stephen P. Goff, Columbia University
1999
Columbia University, New York, NY
1998
Columbia University, New York, NY
1996
Editorial Board Member, International Journal of Molecular Sciences (2021)
Editorial Board Member, Cell and Bioscience and Taiwan Journal of Ophthalmology (2020)
Editorial Board Member, Orphanet Journal of Rare Diseases (2017)
Editorial Board Member, Nature Scientific Reports and Biomed Central Stem Cell Research & Therapy (2016)
Editorial Board Member, Journal of Clinical Investigation Insight (2016)
Fight for Sight/Grant-In-Aid Review Panel Member (2001)